{"id":"placebo-capsule-tablet","safety":{"commonSideEffects":[{"rate":null,"effect":"Nocebo effects (adverse events attributed to placebo expectation)"}]},"_chembl":{"chemblId":"CHEMBL206253","moleculeType":"Small molecule","molecularWeight":"578.60"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo is an inert substance formulated as a capsule or tablet that mimics the appearance of an active drug. It works through psychobiological mechanisms including expectation, conditioning, and the natural history of disease, rather than through direct molecular interaction with disease targets. Placebo effects are well-documented in clinical settings and can produce measurable improvements in subjective symptoms and some objective outcomes.","oneSentence":"Placebo contains no active pharmaceutical ingredient and produces therapeutic effects primarily through the placebo effect—the patient's expectation of benefit.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:42:04.640Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in clinical trials"}]},"trialDetails":[{"nctId":"NCT06631287","phase":"PHASE3","title":"Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID","status":"RECRUITING","sponsor":"Wes Ely","startDate":"2024-10-21","conditions":"Long COVID, Sars-CoV-2 Infection, Coronavirus Infections","enrollment":550},{"nctId":"NCT07266831","phase":"PHASE2, PHASE3","title":"A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-12-18","conditions":"Human Immunodeficiency Virus Type 1 (HIV-1) Infection","enrollment":570},{"nctId":"NCT06450366","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Enlicitide (MK-0616, Oral PCSK9 Inhibitor) Compared With Ezetimibe or Bempedoic Acid or Ezetimibe and Bempedoic Acid in Adults With Hypercholesterolemia (MK-0616-018/CORALreef AddOn)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-07-08","conditions":"Hypercholesterolemia","enrollment":301},{"nctId":"NCT07497685","phase":"NA","title":"Effects of Different Caffeine Forms on Aerobic and Anaerobic Exercise Performance","status":"COMPLETED","sponsor":"University of Gaziantep","startDate":"2024-10-10","conditions":"Exercise Performance, Physical Performance","enrollment":14},{"nctId":"NCT06964776","phase":"PHASE1","title":"A Study of LY4268989 (MORF-057) in Healthy Participants","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2025-05-01","conditions":"Healthy","enrollment":144},{"nctId":"NCT04734080","phase":"PHASE4","title":"Dronabinol in Total Knee Arthroplasty (TKA)","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2021-03-09","conditions":"Total Knee Arthroplasty, Opioid Use","enrollment":114},{"nctId":"NCT05942911","phase":"PHASE2","title":"Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis","status":"TERMINATED","sponsor":"Incannex Healthcare Ltd","startDate":"2023-11-22","conditions":"Rheumatoid Arthritis","enrollment":20},{"nctId":"NCT07498751","phase":"PHASE1","title":"Phase I PK and Safety Study of Ondansetron Inhalation Powder","status":"COMPLETED","sponsor":"Luxena Pharmaceuticals, Inc.","startDate":"2025-03-13","conditions":"Postoperative Nausea and Vomiting","enrollment":24},{"nctId":"NCT07487909","phase":"PHASE1, PHASE2","title":"A Study of SJP-001 in Comparison With Fexofenadine and Naproxen Administered With Alcohol","status":"COMPLETED","sponsor":"Sen-Jam Pharmaceutical","startDate":"2025-09-30","conditions":"Healthy","enrollment":47},{"nctId":"NCT07485842","phase":"PHASE4","title":"FuKe Qianjin Capsule Plus Antibiotics for Chronic Endometritis","status":"NOT_YET_RECRUITING","sponsor":"Tianjin Medical University","startDate":"2026-04","conditions":"Chronic Endometritis","enrollment":300},{"nctId":"NCT07216482","phase":"PHASE3","title":"A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-11-11","conditions":"Hyperlipidemia","enrollment":975},{"nctId":"NCT05263206","phase":"PHASE3","title":"Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)","status":"RECRUITING","sponsor":"Sanofi","startDate":"2022-02-15","conditions":"Pruritus","enrollment":284},{"nctId":"NCT05421858","phase":"PHASE3","title":"A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.","status":"RECRUITING","sponsor":"Basilea Pharmaceutica","startDate":"2024-12-11","conditions":"Candidemia, Candidiasis, Invasive","enrollment":450},{"nctId":"NCT05430152","phase":"PHASE2","title":"Low-dose Naltrexone for Post-COVID Fatigue Syndrome","status":"COMPLETED","sponsor":"Luis Nacul","startDate":"2024-01-15","conditions":"Post-Viral Fatigue Syndrome","enrollment":160},{"nctId":"NCT04191096","phase":"PHASE3","title":"Efficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (MK-3475-991/KEYNOTE-991)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-02-12","conditions":"Metastatic Hormone-Sensitive Prostate Cancer","enrollment":1251},{"nctId":"NCT06307652","phase":"PHASE3","title":"Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2024-04-12","conditions":"Heart Failure and Impaired Kidney Function","enrollment":4800},{"nctId":"NCT07351968","phase":"PHASE1","title":"A Phase Ib Study to Evaluate the Efficacy and Safety of HRS-2129 in Patients With Knee Osteoarthritis","status":"RECRUITING","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2026-03-10","conditions":"Moderate Pain in Knee Osteoarthritis, Severe Pain in Knee Osteoarthritis","enrollment":200},{"nctId":"NCT07267559","phase":"PHASE4","title":"Dual Orexin Antagonism and Emotion and Affective Processing Study","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2025-10-01","conditions":"Learning, Cognitive Functioning, Emotional Processing","enrollment":62},{"nctId":"NCT05653258","phase":"PHASE2, PHASE3","title":"Single Nuclei RNA-seq to Map Adipose Cellular Populations and Senescent Cells in Older Subjects","status":"RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2023-10-17","conditions":"Obesity, Healthy Lifestyle","enrollment":160},{"nctId":"NCT07469462","phase":"NA","title":"The Effects of High-dose Vitamin B6 on Depression and Anxiety Symptoms","status":"RECRUITING","sponsor":"University of Reading","startDate":"2026-02","conditions":"Neural Inhibition, Anxiety, Depression","enrollment":44},{"nctId":"NCT06619860","phase":"PHASE2","title":"Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy","status":"RECRUITING","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2024-10-18","conditions":"Diabetic Peripheral Neuropathic Pain","enrollment":300},{"nctId":"NCT03748641","phase":"PHASE3","title":"A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2019-01-25","conditions":"Castration-Resistant Prostatic Cancer","enrollment":765},{"nctId":"NCT05600062","phase":"NA","title":"Influence of NEP Inhibition on Vascular Leak and Inflammation (NEPi-INFLAMMATION)","status":"RECRUITING","sponsor":"Queen Mary University of London","startDate":"2023-03-21","conditions":"Acute Respiratory Distress Syndrome","enrollment":48},{"nctId":"NCT06231758","phase":"PHASE3","title":"Metformin Safety and Efficacy in Osteoarthritis.","status":"RECRUITING","sponsor":"Mostafa Bahaa","startDate":"2024-01-30","conditions":"Osteo Arthritis Knee","enrollment":70},{"nctId":"NCT07218549","phase":"PHASE1","title":"Evaluation of the Safety and Effects of Psychoactive Substances in People With Past Opioid Use","status":"NOT_YET_RECRUITING","sponsor":"Christopher D. Verrico","startDate":"2026-05-01","conditions":"Opioid Use, Substance Use Disorders, Opioid Analgesia","enrollment":72},{"nctId":"NCT07461402","phase":"NA","title":"Plant Protein With Ashwagandha-Rhodiola for Sleep Quality","status":"COMPLETED","sponsor":"Universidad Pablo de Olavide","startDate":"2025-11-01","conditions":"Sleep Quality, Sleep Disorders, Insomnia","enrollment":100},{"nctId":"NCT05147220","phase":"PHASE3","title":"Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2021-12-16","conditions":"Relapsing Multiple Sclerosis","enrollment":1001},{"nctId":"NCT06671483","phase":"PHASE3","title":"A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines","status":"RECRUITING","sponsor":"Takeda","startDate":"2025-03-03","conditions":"Psoriatic Arthritis","enrollment":1088},{"nctId":"NCT04915183","phase":"PHASE2","title":"Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer","status":"RECRUITING","sponsor":"National Institute on Deafness and Other Communication Disorders (NIDCD)","startDate":"2024-07-10","conditions":"Hearing Loss, Head and Neck Cancer","enrollment":224},{"nctId":"NCT05986318","phase":"PHASE2","title":"Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease","status":"RECRUITING","sponsor":"David Palma","startDate":"2025-01-07","conditions":"Lung Cancer, Interstitial Lung Disease","enrollment":98},{"nctId":"NCT07454408","phase":"PHASE1, PHASE2","title":"Evaluation of the Outcome of Fecal Microbiota Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Air Force Military Medical University, China","startDate":"2026-03-07","conditions":"Hepatic Encephalopathy, Fecal Microbiota Transplantation, TIPS","enrollment":40},{"nctId":"NCT06566794","phase":"NA","title":"KF2022#4-trial: Effects of a Beta Blocker and NSAID on CYP Mediated Drug Metabolism","status":"COMPLETED","sponsor":"Helsinki University Central Hospital","startDate":"2024-08-22","conditions":"Drug Interaction","enrollment":12},{"nctId":"NCT07456176","phase":"PHASE3","title":"Effect of Low-Dose Versus High-Dose Alpha-Lipoic Acid on Oxidative Stress, Inflammation, and Clinical Outcomes in Acute Exacerbations of Chronic Obstructive Pulmonary Disease","status":"NOT_YET_RECRUITING","sponsor":"Ain Shams University","startDate":"2026-02-28","conditions":"Acute Exacerbation Chronic Obstructive Pulmonary Disease","enrollment":75},{"nctId":"NCT04302870","phase":"PHASE2, PHASE3","title":"Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised Trial","status":"RECRUITING","sponsor":"University of Edinburgh","startDate":"2020-02-27","conditions":"Motor Neuron Disease, Amyotrophic Lateral Sclerosis","enrollment":1150},{"nctId":"NCT07377721","phase":"PHASE1","title":"A Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic Pain","status":"NOT_YET_RECRUITING","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2026-02","conditions":"Diabetic Peripheral Neuropathic Pain","enrollment":168},{"nctId":"NCT07342491","phase":"PHASE1","title":"Dasatinib for HIV-1 Reservoir Reduction","status":"NOT_YET_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-03-02","conditions":"HIV Infections","enrollment":14},{"nctId":"NCT04224493","phase":"PHASE3","title":"A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.","status":"RECRUITING","sponsor":"Epizyme, Inc.","startDate":"2020-06-11","conditions":"Relapsed/Refractory Follicular Lymphoma, Follicular Lymphoma, Refractory Follicular Lymphoma","enrollment":612},{"nctId":"NCT05771675","phase":"EARLY_PHASE1","title":"Simvastatin Treatment to Improve Patient-reported Outcomes in Patients With Chronic Pancreatitis","status":"RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2024-10-24","conditions":"Recurrent Acute Pancreatitis, Chronic Pancreatitis","enrollment":90},{"nctId":"NCT03598309","phase":"PHASE2","title":"Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers","status":"ACTIVE_NOT_RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2019-06-05","conditions":"Lung Diseases, Lung Cancer, Protection Against","enrollment":19},{"nctId":"NCT07028385","phase":"PHASE2","title":"Safety and Impact of Baricitinib on Cell Surivival Pathways, HIV-1 Reservoir and Inflamation in People With HIV-1","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia","startDate":"2025-09-22","conditions":"HIV","enrollment":30},{"nctId":"NCT03016819","phase":"PHASE3","title":"Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)","status":"RECRUITING","sponsor":"Advenchen Laboratories, LLC","startDate":"2017-08-15","conditions":"Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma","enrollment":325},{"nctId":"NCT07266805","phase":"PHASE3","title":"Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency","status":"RECRUITING","sponsor":"Pharvaris Netherlands B.V.","startDate":"2025-10-16","conditions":"Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH)","enrollment":32},{"nctId":"NCT07429565","phase":"PHASE1","title":"Testing APPA-1 in Healthy Subjects and Osteoarthritis Patients","status":"COMPLETED","sponsor":"University of Liverpool","startDate":"2018-04-09","conditions":"Osteoarthritis","enrollment":40},{"nctId":"NCT07421427","phase":"NA","title":"Adding Amantadine or Duloxetine to Pregabalin on Occurrence of Post Mastectomy Pain Syndrome","status":"RECRUITING","sponsor":"Cairo University","startDate":"2026-02-21","conditions":"Amantadine, Duloxetine, Pregabalin","enrollment":150},{"nctId":"NCT07424781","phase":"NA","title":"Fluoxetine on Emotional Experience (FLEX) Study","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2025-10-01","conditions":"Depression - Major Depressive Disorder, Irritability, Depression","enrollment":80},{"nctId":"NCT06611501","phase":"PHASE2","title":"Glycemic Regulation as Endometriosis Adjunct Treatment","status":"RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2025-05-22","conditions":"Pelvic Pain, Endometriosis","enrollment":14},{"nctId":"NCT04926818","phase":"PHASE3","title":"Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2021-10-05","conditions":"Multiple Sclerosis (MS)","enrollment":129},{"nctId":"NCT04922333","phase":"PHASE3","title":"Bisphosphonate Use to Mitigate Bone Loss Secondary to Bariatric Surgery","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2023-03-28","conditions":"Bone Loss","enrollment":200},{"nctId":"NCT03229889","phase":"PHASE4","title":"Trial of Tadalafil, Tamsulosin and Combination for Access Sheath Deployment","status":"COMPLETED","sponsor":"University of California, Irvine","startDate":"2017-06-07","conditions":"Nephrolithiasis","enrollment":220},{"nctId":"NCT07385937","phase":"NA","title":"Effectiveness of Genistein in Mild Cognitive Impairment","status":"NOT_YET_RECRUITING","sponsor":"Universidad Católica San Antonio de Murcia","startDate":"2026-02","conditions":"Alzheimer Disease (AD), Mild Cognitive Impairment (MCI)","enrollment":150},{"nctId":"NCT07414212","phase":"PHASE1, PHASE2","title":"Evaluation of the Combined Therapy of EH-301 and N-acetylcysteine Together With Riluzole in Amyotrophic Lateral Sclerosis (ALS)","status":"RECRUITING","sponsor":"Biogipuzkoa Health Research Institute","startDate":"2025-11-25","conditions":"Amyotrophic Lateral Sclerosis","enrollment":90},{"nctId":"NCT07411482","phase":"NA","title":"The Effect of Probiotic Supplementation on the Exercise Performance of Long-distance Runners.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medical University of Gdansk","startDate":"2023-12-01","conditions":"Intestinal Microbiome, Probiotic, Runners","enrollment":27},{"nctId":"NCT07408232","phase":"PHASE1, PHASE2","title":"A Phase 1/2 Study in Healthy Volunteers and Participants With Autosomal Dominant Retinitis Pigmentosa (RHO-adRP)","status":"RECRUITING","sponsor":"Octant, Inc.","startDate":"2026-02-09","conditions":"Retinitis Pigmentosa","enrollment":50},{"nctId":"NCT05995535","phase":"PHASE2","title":"Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2024-01-01","conditions":"Opiate Withdrawal Syndrome, Opioid Use","enrollment":150},{"nctId":"NCT07406035","phase":"PHASE2","title":"A Phase II Clinical Trial to Evaluate the Efficacy and Safety of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis","status":"NOT_YET_RECRUITING","sponsor":"Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.","startDate":"2026-04","conditions":"Psoriatic Arthritis","enrollment":156},{"nctId":"NCT07407400","phase":"PHASE4","title":"Lemborexant for Sleep and Delirium Prevention in Elderly ICU Patients","status":"NOT_YET_RECRUITING","sponsor":"Mahidol University","startDate":"2026-04-01","conditions":"Sleep Disturbance, Delirium, Critical Illness","enrollment":100},{"nctId":"NCT07407634","phase":"EARLY_PHASE1","title":"A Randomized, Double-blind, Single-center Phase I/IIa Study of XTYW007 Tablets in Subjects.","status":"NOT_YET_RECRUITING","sponsor":"Xi'an Xintong Pharmaceutical Research Co.,Ltd.","startDate":"2026-03-25","conditions":"Non-Alcoholic Fatty Liver Disease","enrollment":94},{"nctId":"NCT04303065","phase":"PHASE3","title":"Trial of Dexamethasone for Traumatic Brain Injured Patients With Brain Contusions and Pericontusional Edema","status":"TERMINATED","sponsor":"Jon Pérez Bárcena","startDate":"2020-07-24","conditions":"Traumatic Brain Injury, Cerebral Edema, Head Injury Trauma","enrollment":600},{"nctId":"NCT06229678","phase":"EARLY_PHASE1","title":"Ketones, SGLT2, HFrEF","status":"RECRUITING","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2024-01-25","conditions":"Type2diabetes, Heart Failure With Reduced Ejection Fraction","enrollment":71},{"nctId":"NCT07388576","phase":"NA","title":"A Clinical Trial to Investigate the Safety and Efficacy of AP-Brain on Cognitive Function at Varying Dosages in Healthy Younger Adults With Self-reported Attention Problems","status":"NOT_YET_RECRUITING","sponsor":"Rousselot BVBA","startDate":"2026-03","conditions":"Cognition, Cognitive Function","enrollment":120},{"nctId":"NCT04624243","phase":"PHASE2","title":"Efficacy and Safety of MK-8189 in Participants With an Acute Episode of Schizophrenia (MK-8189-008)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-12-15","conditions":"Schizophrenia","enrollment":499},{"nctId":"NCT07388043","phase":"NA","title":"A Clinical Trial to Investigate the Safety and Efficacy of AP-Brain on Cognitive Function at Varying Dosages in Healthy Middle-aged and Older Adults With Self-reported Memory Problems","status":"NOT_YET_RECRUITING","sponsor":"Rousselot BVBA","startDate":"2026-03","conditions":"Cognition, Cognitive Function","enrollment":120},{"nctId":"NCT04487080","phase":"PHASE3","title":"A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2020-09-30","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":1074},{"nctId":"NCT04509102","phase":"EARLY_PHASE1","title":"Psychostimulant Augmentation of Repetitive TMS for the Treatment of Major Depressive Disorder","status":"ENROLLING_BY_INVITATION","sponsor":"University of California, Los Angeles","startDate":"2021-09-27","conditions":"Major Depressive Disorder","enrollment":30},{"nctId":"NCT06628908","phase":"PHASE3","title":"Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy","status":"RECRUITING","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2024-10-01","conditions":"Diabetic Peripheral Neuropathic Pain","enrollment":1100},{"nctId":"NCT06845124","phase":"PHASE2","title":"A Trial to Investigate the Effects of Cannabidiol Plus Naltrexone on Alcohol Craving in Patients With Alcohol Dependence","status":"RECRUITING","sponsor":"Central Institute of Mental Health, Mannheim","startDate":"2025-07-22","conditions":"Alcohol Addiction, Alcoholism","enrollment":150},{"nctId":"NCT05156281","phase":"PHASE3","title":"Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2021-12-13","conditions":"Relapsing Multiple Sclerosis","enrollment":1011},{"nctId":"NCT03341078","phase":"PHASE2","title":"Pilot Study of the Effect of Ibudilast on Neuroinflammation in Methamphetamine Users","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2019-05-01","conditions":"Methamphetamine-dependence","enrollment":176},{"nctId":"NCT07370220","phase":"PHASE2","title":"Effect of Rutin on Inflammation Pathways in Ulcerative Colitis Patients","status":"COMPLETED","sponsor":"Benha University","startDate":"2025-02-22","conditions":"Ulcerative Colitis","enrollment":60},{"nctId":"NCT04564547","phase":"PHASE2","title":"Dose Ranging, Switch Study of Islatravir (MK-8591) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013]","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2021-03-09","conditions":"HIV-1 Infection","enrollment":161},{"nctId":"NCT03482479","phase":"PHASE2","title":"Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2019-02-04","conditions":"Eosinophilic Granulomatosis With Polyangiitis (EGPA), Churg-Strauss Syndrome (CSS), Giant Cell Arteritis","enrollment":60},{"nctId":"NCT03667326","phase":"PHASE2","title":"Postpartum Low-Dose Aspirin and Preeclampsia","status":"RECRUITING","sponsor":"Columbia University","startDate":"2019-07-22","conditions":"Preeclampsia Postpartum","enrollment":100},{"nctId":"NCT06269484","phase":"PHASE2","title":"A Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Participants With Cirrhosis-ZEAL-UNLOCK","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2024-02-15","conditions":"Liver Cirrhosis","enrollment":73},{"nctId":"NCT04679376","phase":"PHASE2","title":"Statins for the Treatment of NASH","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2023-01-25","conditions":"NASH - Nonalcoholic Steatohepatitis","enrollment":70},{"nctId":"NCT04964934","phase":"PHASE3","title":"Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2021-06-30","conditions":"ER-Positive HER2-Negative Breast Cancer","enrollment":315},{"nctId":"NCT04516967","phase":"PHASE3","title":"Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months","status":"COMPLETED","sponsor":"Sobi, Inc.","startDate":"2021-03-05","conditions":"Immune Thrombocytopenia","enrollment":75},{"nctId":"NCT01988883","phase":"EARLY_PHASE1","title":"Modafinil and Cognitive Function in POTS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2014-10","conditions":"Postural Tachycardia Syndrome","enrollment":20},{"nctId":"NCT06698926","phase":"PHASE1","title":"A Study to Assess the Safety, Tolerability, and Interactions of ABBV-CLS-616 Oral Tablets in Healthy Adult Participants","status":"COMPLETED","sponsor":"AbbVie","startDate":"2024-11-11","conditions":"Healthy Volunteer","enrollment":110},{"nctId":"NCT06967857","phase":"PHASE2","title":"Clinical Trial to Investigate the Safety and Efficacy of Two Dexamfetamine Sulfate Formulations in Adults With ADHD and Moderate to Severe Depression","status":"RECRUITING","sponsor":"Prof. Dr. Frank Behrens","startDate":"2025-05-15","conditions":"Attention-Deficit/Hyperactivity Disorder (ADHD), Depression - Major Depressive Disorder","enrollment":105},{"nctId":"NCT06236061","phase":"PHASE3","title":"Study of Efficacy and Safety of LCZ696/Amlodipine in Grade 1 and 2 Hypertension Patients Uncontrolled by LCZ696 Monotherapy","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2024-04-08","conditions":"Hypertension","enrollment":718},{"nctId":"NCT05056727","phase":"PHASE3","title":"A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia","status":"TERMINATED","sponsor":"AstraZeneca","startDate":"2021-09-30","conditions":"Renal Insufficiency, Chronic, Hyperkalemia","enrollment":1112},{"nctId":"NCT03621553","phase":"PHASE4","title":"Vitamin D Homeostasis in Sarcoidosis","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2010-07-01","conditions":"Sarcoidosis, Vitamin D Insufficiency","enrollment":90},{"nctId":"NCT07303088","phase":"NA","title":"Effects of L-carnitine and Coenzyme Q10 Supplementation on Oxidative Stress in Tunisian Hemodialysis Patients.","status":"COMPLETED","sponsor":"University of Sfax","startDate":"2024-06-17","conditions":"Oxidative Stress Response, Hemodialysis, End Stage Kidney Disease (ESRD)","enrollment":52},{"nctId":"NCT04231708","phase":"PHASE2","title":"Effects of Pharmacological Stress and rTMS on Executive Function in Opioid Use Disorder","status":"NOT_YET_RECRUITING","sponsor":"Wayne State University","startDate":"2026-10","conditions":"Opioid Use Disorder","enrollment":20},{"nctId":"NCT05892432","phase":"PHASE2","title":"Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder (AUD)","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2024-01-11","conditions":"Alcohol Use Disorder","enrollment":50},{"nctId":"NCT06040190","phase":"PHASE4","title":"Effect of Treatments on Pain and Quality of Life in Individual With Burning Mouth Syndrome","status":"RECRUITING","sponsor":"Federal University of Minas Gerais","startDate":"2023-11-01","conditions":"Burning Mouth Syndrome","enrollment":150},{"nctId":"NCT07298564","phase":"NA","title":"Effect of Magnesium and Levocarnitine on Metabolic and Clinical Outcomes in Women With Polycystic Ovarian Syndrome (PCOS)","status":"RECRUITING","sponsor":"Behnood Abbasi","startDate":"2026-01-30","conditions":"Polycystic Ovary Syndrome (PCOS)","enrollment":84},{"nctId":"NCT05418049","phase":"PHASE2","title":"Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug Challenge","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2022-09-08","conditions":"Fragile X Syndrome","enrollment":45},{"nctId":"NCT04579848","phase":"PHASE4","title":"Methotrexate in Erosive Inflammatory Hand Osteoarthritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Diakonhjemmet Hospital","startDate":"2021-08-12","conditions":"Hand Osteoarthritis, Erosive Osteoarthritis","enrollment":163},{"nctId":"NCT06338553","phase":"EARLY_PHASE1","title":"GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2024-06-12","conditions":"Type 1 Diabetes","enrollment":24},{"nctId":"NCT07282821","phase":"PHASE2","title":"Bempedoic Acid Therapy for Polycystic Kidney Disease","status":"NOT_YET_RECRUITING","sponsor":"Kenneth Hallows","startDate":"2026-02-01","conditions":"ADPKD (Autosomal Dominant Polycystic Kidney Disease)","enrollment":120},{"nctId":"NCT06973291","phase":"PHASE3","title":"A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Takeda","startDate":"2025-07-09","conditions":"Plaque Psoriasis","enrollment":606},{"nctId":"NCT05077332","phase":"PHASE2","title":"LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)","status":"COMPLETED","sponsor":"Leidos Life Sciences","startDate":"2021-12-29","conditions":"2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease","enrollment":4},{"nctId":"NCT07135687","phase":"PHASE4","title":"Study to Use Oral Losartan to Decrease the Risk of Postoperative Scarring Following (ACL) Reconstruction","status":"NOT_YET_RECRUITING","sponsor":"Rush University Medical Center","startDate":"2026-08","conditions":"ACL Injury, ACL Reconstruction, Scar Formation","enrollment":144},{"nctId":"NCT07273799","phase":"PHASE3","title":"Comparison of Outcomes Between Topical Minoxidil Versus Oral Minoxidil for the Treatment of Androgenetic Alopecia","status":"NOT_YET_RECRUITING","sponsor":"Sheikh Zayed Federal Postgraduate Medical Institute","startDate":"2025-12-20","conditions":"Androgenic Alopecia","enrollment":200},{"nctId":"NCT06148025","phase":"PHASE4","title":"Antibiotics and Vaccine Immune Responses Study","status":"RECRUITING","sponsor":"South Australian Health and Medical Research Institute","startDate":"2023-11-23","conditions":"Vaccine Response Impaired","enrollment":348},{"nctId":"NCT06588738","phase":"PHASE3","title":"A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alumis Inc","startDate":"2024-08-20","conditions":"Plaque Psoriasis","enrollment":840},{"nctId":"NCT06586112","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque Psoriasis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alumis Inc","startDate":"2024-07-25","conditions":"Plaque Psoriasis","enrollment":840},{"nctId":"NCT06354088","phase":"PHASE1","title":"Human Models of Selective Insulin Resistance: Alpelisib, Part I","status":"RECRUITING","sponsor":"Columbia University","startDate":"2024-04-24","conditions":"Insulin Resistance, Prediabetic State, Overweight and Obesity","enrollment":32},{"nctId":"NCT04185441","phase":"PHASE3","title":"Efficacy and Safety of Tanzânia Association in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia","status":"COMPLETED","sponsor":"EMS","startDate":"2021-03-14","conditions":"Erectile Dysfunction, Benign Prostatic Hyperplasia","enrollment":295}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Placebo"],"phase":"marketed","status":"active","brandName":"Placebo (Capsule/Tablet)","genericName":"Placebo (Capsule/Tablet)","companyName":"Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics","companyId":"gasherbrum-bio-inc-a-wholly-owned-subsidiary-of-structure-therapeutics","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo contains no active pharmaceutical ingredient and produces therapeutic effects primarily through the placebo effect—the patient's expectation of benefit. Used for Control arm in clinical trials.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}